First-line Intravesical Chemotherapy for Non-muscle-invasive Bladder Cancer: Chimera or "Ne Plus Ultra"?
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 36941147.
- Also identified by DOI 10.1016/j.eururo.2023.02.026.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The efficacy of first-line intravesical chemotherapy for non-muscle-invasive bladder cancer has been tested in the neoadjuvant and chemoresection settings. However, the data available are highly heterogeneous and further high-quality studies are needed before its use can be embraced in either setting.
Medical subject headings
- Non-Muscle Invasive Bladder Neoplasms
- Urinary Bladder Neoplasms